Published in Eur J Gastroenterol Hepatol on November 01, 2015
Prediction of pneumonia hospitalization in adults using health checkup data. PLoS One (2017) 0.75
Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA (2004) 6.06
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut (1972) 4.59
Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care (2004) 4.39
Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine (Baltimore) (1971) 3.57
Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients. Am J Med (1976) 3.36
The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2005) 3.24
Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax (1999) 2.91
Pernicious anemia. N Engl J Med (1997) 2.89
Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med (2007) 2.85
Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med (2008) 1.99
Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol (1998) 1.90
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol (2003) 1.80
Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol (2011) 1.78
Influence of gastric pH on gastric and jejunal flora. Gut (1967) 1.45
Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study. Pharmacoepidemiol Drug Saf (2009) 1.37
Safety of proton pump inhibitor exposure. Gastroenterology (2010) 1.37
Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network. Pharmacoepidemiol Drug Saf (2012) 1.34
Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH. Eur J Clin Pharmacol (2008) 1.26
Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia. Aliment Pharmacol Ther (2010) 1.21
Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis. Expert Rev Clin Pharmacol (2012) 1.15
Can primary care data be used to monitor regional smoking prevalence? An analysis of The Health Improvement Network primary care data. BMC Public Health (2011) 1.13
Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease. Pharmacoepidemiol Drug Saf (2011) 1.11
Acid-suppressive drugs and community-acquired pneumonia. Epidemiology (2009) 1.06
Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study. Pharmacoepidemiol Drug Saf (2010) 1.04
Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network. Pharmacoepidemiol Drug Saf (2014) 1.04
Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs. Am J Med (2010) 1.02
Pernicious anaemia, intragastric bacterial overgrowth, and possible consequences. Scand J Gastroenterol (1984) 0.95
The syndrome of immunoglobulin deficiency and pernicious anemia. A study of ten cases. Am J Med (1969) 0.94
Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed. Clin Infect Dis (2011) 0.92
Pernicious anemia and monoclonal gammopathy in a patient with IgA deficiency. Am J Med (1970) 0.89
Accuracy of pneumonia hospital admissions in a primary care electronic medical record database. Pharmacoepidemiol Drug Saf (2012) 0.85
Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA (2006) 9.53
Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ (2013) 3.22
Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol (2003) 2.20
Achalasia: a disease of varied and subtle symptoms that do not correlate with radiographic findings. Am J Gastroenterol (2002) 2.16
Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease. Eur J Gastroenterol Hepatol (2005) 2.15
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum (2012) 2.15
Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics (2012) 2.04
Importance of surveillance for multiple endocrine neoplasia-1 and surgery in patients with sporadic Zollinger-Ellison syndrome. Clin Gastroenterol Hepatol (2012) 2.00
Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med (2008) 1.99
Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion (2011) 1.80
Physician attitudes toward regionalization of adult critical care: a national survey. Crit Care Med (2009) 1.79
Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med (2004) 1.72
A randomized, controlled, double-blind trial of patient-controlled sedation with propofol/remifentanil versus midazolam/fentanyl for colonoscopy. Anesth Analg (2008) 1.71
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst (2012) 1.69
Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas (2013) 1.65
Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis (2004) 1.63
Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection. Pharmacoepidemiol Drug Saf (2009) 1.61
A prospective, randomized, comparative trial evaluating respiratory depression during patient-controlled versus anesthesiologist-administered propofol-remifentanil sedation for elective colonoscopy. Gastrointest Endosc (2010) 1.57
Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. J Natl Cancer Inst (2014) 1.50
Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig Dis Sci (2007) 1.50
Ineffective motility is not a marker for gastroesophageal reflux disease. Am J Gastroenterol (2003) 1.50
Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infect Control Hosp Epidemiol (2014) 1.45
Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study. J Clin Psychiatry (2015) 1.43
Hypochlorhydria and achlorhydria are associated with false-positive secretin stimulation testing for Zollinger-Ellison syndrome. Pancreas (2013) 1.41
A case of Cronkhite-Canada syndrome with taste disturbance as a leading complaint. Digestion (2005) 1.41
Safety of proton pump inhibitor exposure. Gastroenterology (2010) 1.37
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Pharmacoepidemiol Drug Saf (2011) 1.30
Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database. Pharmacoepidemiol Drug Saf (2013) 1.23
Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. Hepatology (2012) 1.16
Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) (2012) 1.15
Successful aspiration and ethanol sclerosis of a large, symptomatic, simple liver cyst: case presentation and review of the literature. World J Gastroenterol (2006) 1.12
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. Am J Med (2010) 1.11
Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease. Pharmacoepidemiol Drug Saf (2011) 1.11
Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Ann Rheum Dis (2012) 1.08
Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms. Obstet Gynecol (2008) 1.07
No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clin Gastroenterol Hepatol (2011) 1.05
Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events. J Clin Epidemiol (2008) 1.05
Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network. Pharmacoepidemiol Drug Saf (2014) 1.04
Do diabetes drugs modify the risk of pancreatic cancer? Gastroenterology (2009) 1.04
Management of patients with nonvariceal upper gastrointestinal bleeding. Clin Gastroenterol Hepatol (2011) 1.03
Metformin and survival in pancreatic cancer: a retrospective cohort study. Pancreas (2013) 1.03
Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care (2005) 1.00
Uses of proton pump inhibitors and hypomagnesemia. Pharmacoepidemiol Drug Saf (2012) 0.99
Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol (2005) 0.98
Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure. Pharmacoepidemiol Drug Saf (2006) 0.97
Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study. Cancer (2012) 0.96
Hip fracture risk in patients with a diagnosis of pernicious anemia. Gastroenterology (2009) 0.93
Distinguishing incident and prevalent diabetes in an electronic medical records database. Pharmacoepidemiol Drug Saf (2013) 0.93
Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature. World J Gastroenterol (2005) 0.93
Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology (2005) 0.91
Radiographic appearance of a catheter-free wireless esophageal pH probe. AJR Am J Roentgenol (2005) 0.91
Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding events. J Gen Intern Med (2008) 0.89
Insulin therapy and colorectal adenomas in patients with diabetes mellitus. Cancer Epidemiol Biomarkers Prev (2012) 0.88
Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population. Pharmacoepidemiol Drug Saf (2008) 0.88
Hepatitis C knowledge among primary care residents: is our teaching adequate for the times? Am J Gastroenterol (2004) 0.88
Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity. Pharmacoepidemiol Drug Saf (2008) 0.87
Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study. Pharmacoepidemiol Drug Saf (2014) 0.87
Use of antiepileptic drugs in patients with kidney disease. Semin Dial (2006) 0.87
Pharmacogenomics training using an instructional software system. Am J Pharm Educ (2011) 0.87
Emergent renal dysfunction with colistin pharmacotherapy. Pharmacotherapy (2013) 0.86
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies. Pharmacoepidemiol Drug Saf (2012) 0.86
Clostridium difficile colitis: wash your hands before stopping the proton pump inhibitor. Am J Gastroenterol (2008) 0.85
Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design. Inj Prev (2012) 0.85
Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients. Arthritis Care Res (Hoboken) (2015) 0.85
Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures. J Clin Epidemiol (2007) 0.85
Uses of proton pump inhibitors and serum potassium levels. Pharmacoepidemiol Drug Saf (2009) 0.84
Risks and benefits of menopausal hormone therapy in postmenopausal Chinese women. Menopause (2012) 0.84
Association between model for end-stage liver disease and spontaneous bacterial peritonitis. Am J Gastroenterol (2007) 0.84
Long-term outcome of laparoscopic Nissen and laparoscopic Toupet fundoplication for gastroesophageal reflux disease: a prospective, randomized trial. Surg Endosc (2009) 0.82
Digoxin use and the risk for colorectal cancer. Pharmacoepidemiol Drug Saf (2014) 0.82
Impact of antibiotic exposure on the risk of colorectal cancer. Pharmacoepidemiol Drug Saf (2015) 0.81
Risk factors for aggressive nonfunctional pancreatic neuroendocrine tumors and the role of endoscopic ultrasound guided fine-needle aspiration. Endosc Ultrasound (2016) 0.81
Influence of age and gender on gastric acid secretion as estimated by integrated acidity in patients referred for 24-hour ambulatory pH monitoring. Am J Gastroenterol (2003) 0.80
Observational cohort study of the safety of digoxin use in women with heart failure. BMJ Open (2012) 0.80
Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer. Am J Gastroenterol (2005) 0.79
The efficacy of endoscopic therapy in bleeding peptic ulcer patients. S Afr Med J (2012) 0.79
Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology (2005) 0.79
Barrett's esophagus in 2008: an update. Keio J Med (2008) 0.79
PTCH 1 staining of pancreatic neuroendocrine tumor (PNET) samples from patients with and without multiple endocrine neoplasia (MEN-1) syndrome reveals a potential therapeutic target. Cancer Biol Ther (2015) 0.79
Changes of the HSD17B10 gene expression levels in ulcerative colitis. Inflamm Bowel Dis (2013) 0.78
Electronic clinical laboratory test results data tables: lessons from Mini-Sentinel. Pharmacoepidemiol Drug Saf (2014) 0.78
Findings on serial surveillance colonoscopy in patients with low-risk polyps on initial colonoscopy. J Clin Gastroenterol (2010) 0.77
Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms. Scand J Gastroenterol (2006) 0.77
Ghrelin does not predict adaptive hyperphagia in patients with short bowel syndrome. JPEN J Parenter Enteral Nutr (2009) 0.77
Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial. Dig Dis Sci (2006) 0.77
Proton pump inhibitors do not impair the effectiveness of metformin in patients with diabetes. Br J Clin Pharmacol (2015) 0.77
Gastroesophageal reflux and sleep events in obstructive sleep apnea. Eur J Gastroenterol Hepatol (2013) 0.76
Height as an independent anthropomorphic risk factor for colorectal cancer. Eur J Gastroenterol Hepatol (2014) 0.76
Oxyntic mucosa pseudopolyps: a presentation of atrophic autoimmune gastritis. Am J Surg Pathol (2003) 0.76
Diagnosis of pernicious anemia and the risk of pancreatic cancer. Pancreas (2014) 0.75
Therapy for gastroesophageal reflux disease: more is not necessarily better. Am J Gastroenterol (2003) 0.75
HNPCC-associated pheochromocytoma: expanding the tumor spectrum. Pancreas (2015) 0.75
Segmental increases in force application during colonoscope insertion: quantitative analysis using force monitoring technology. Gastrointest Endosc (2012) 0.75